帕博利珠单抗治疗初治PD-L1阳性局部晚期/转移性非小细胞肺癌:KEYNOTE-042中国拓展研究

摘要

cqvip:1 文献来源Wu YL,Zhang L,Fan Y,et al.Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD-L1-positive locally advanced or metastatic non-small-cell lung cancer:KEYNOTE-042 China Study [J].Int J Cancer,2021,148(9):2313-2320.2 证据水平1b。